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SUMMARY
Doxorubicin has been largely used in anticancer therapy in adults, adolescents, and children. The efficacy of L-carnitine as an
antioxidant substance has been confirmed both in humans and rats. Carnitine, present in testis and epididymis, is involved in sperm
maturation. It is also effective in infertility treatment. As a continuation of a previous study, we evaluated whether some spermatic
qualitative parameters, DNA integrity, chromatin structure, and fertility status, could be ameliorated by the carnitine treatment in
adult rats, which were subsequently exposed to doxorubicin at pre-puberty. Pre-pubertal male rats were distributed into four groups:
Sham Control; Doxorubicin; L-carnitine; L-carnitine + Doxorubicin (L-carnitine injected 1 h before doxorubicin). At 100 days of age,
all groups were reassigned into two sets: One set was submitted to the evaluation of sperm motility, acrosome integrity, mitochon-
drial activity, sperm chromatin structure analysis (SCSA), and evaluation of the oxidative stress. The other set of rats was destined to
the evaluation of reproductive competence. The percentage of spermatozoa with intact acrosome integrity was higher in the Car-
nitine+Doxorubicin group when compared with the Doxorubicin group. However, sperm motility and mitochondrial activity were
not improved by carnitine pre-treatment. Both values of malondialdehyde and nitrite (indirect measurement of nitric oxide) concen-
trations were statistically higher in the only doxorubicin-treated group when compared to the Carnitine + Doxorubicin group. Fertil-
ity index and implantation rate were lower in Doxorubicin group, when compared to Carnitine + Doxorubicin group. Moreover, the
percentage of spermatozoa with damaged DNA was higher in the Doxorubicin-treated group when compared to the Carnitine+Dox-
orubicin group. L-carnitine, when administered before doxorubicin, partially preserved the acrosome integrity, an important feature
related to sperm fertilization ability that positively correlated with the reproductive competence and sperm DNA integrity at adult-
hood. In conclusion, L-carnitine attenuated the long-term alterations caused by doxorubicin in the germ cells and improved male
reproductive capacity in adulthood.
INTRODUCTION
Doxorubicin has been largely used in anticancer therapy in
adults, adolescents, and children (M€uller et al., 2011). Acute
lymphocytic leukemia (ALL), lymphoma (Hodgkin and non-
Hodgkin), and neuroblastoma are the commonest childhood
cancers against which doxorubicin is proven to be effective
(Hopkins-Donaldson et al., 2002; Caze et al., 2010; M€uller et al.,
2011). Many mechanisms of action have been proposed to justify
the efficacy of doxorubicin; among them, the inhibition of topoi-
somerase II is known to be a key mechanism of its antiprolifera-
tive action (Tewey et al., 1984). DNA intercalation and
generation of free radicals are also cytotoxic effects of
doxorubicin that result in the cell proliferation control and death
(Tritton et al., 1978; Hida et al., 1995; Stevens et al., 2007; Patel
& Kaufmann, 2012). However, doxorubicin does not affect exclu-
sively neoplastic cells, but also healthy dividing cells, for
instance the spermatogonia (Jahnukainen et al., 2000; Ven-
dramini et al., 2010).
According to the data compiled by the Childhood Cancer Sur-
vival Study (CCSS), a cohort study funded by the National Can-
cer Institute and other organizations, the survivor population
who undertook chemotherapy during childhood or adolescence
can be at increased risk of a broad spectrum of adverse out-
comes, such as heart failure, nerve damage, second cancers,
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pregnancy loss, giving birth to offspring with low birthweights,
and decreased educational attainment. Indeed, patients that had
a diagnosis of Hodgkin’s lymphoma enrolled in the survey,
which probably received doxorubicin as part of their therapy,
were least likely to sire a pregnancy than their siblings (Green
et al., 2010).
In an attempt to help those patients to overcome a certain or
an imminent infertility in the future, techniques such as pre-
pubertal testicular tissue cryopreservation, spermatogonium
culture, and cytoprotection of the seminiferous epithelium
should be considered (Wyns et al., 2010).
Various studies have demonstrated that the use of cytoprotec-
tors can contribute to reducing or attenuating the unwanted side
effects of anticancer drugs aiming to promote a better quality of
life of the survivors (Khan et al., 2010; Chao et al., 2011; Khosit-
seth et al., 2011; Lamas et al., 2015). In the case of doxorubicin,
preventive strategies are generally directed to the prevention of
cardiotoxicity (Octavia et al., 2012), but as infertility is also one
of the aspects to measure quality of life (Monga et al., 2004), sev-
eral studies have been addressing new perspectives for fertility
preservation.
L-carnitine is very widely considered as an effective substance
to treat infertility (Lenzi et al., 2003; Cavallini et al., 2004) and is
also a promising candidate for adjuvant therapy with the aim to
reduce multiple organ toxicity after anticancer treatments
(Sayed-Ahmed, 2010). It is naturally found in our body due to its
physiological function and its efficiency in promoting the oxida-
tion of long-chain fatty acids in the mitochondria (Bremer,
1962). More recently, additional mechanisms of carnitine were
described, as the removal of excess acyl groups in various tissues
and the modulation of intracellular coenzyme A (CoA) home-
ostasis (Ramsay & Arduini, 1993; Hoppel, 2003). In the testis and
epididymis, it is found in large amounts, but is in a higher con-
centration in this last one, which is an expected feature consid-
ering the involvement of the epididymis in sperm maturation
and motility acquisition (Jeulin & Lewin, 1996; Ng et al., 2004).
The efficacy of L-carnitine as an antioxidant has been observed
in both humans (Waldner et al., 2006) and rats (Vicari et al.,
2002; Alshabanah et al., 2010). However, there are no reports
relating the protection of carnitine against the oxidative stress
produced by doxorubicin in the testis.
According to G€ulcin (2006), carnitine is a potent free radical
scavenger, especially to superoxide anion, which is involved in
the formation of hydrogen peroxide and hydroxyl radicals,
known inducers of oxidative damage in the germ cells and/or
sperm membrane, as well as in the DNA (Aitken & Roman,
2008).
The protective action of carnitine on male germ cells deple-
tion, in rats, was already described as effective against the dam-
age caused by gamma radiation (Topcu-Tarladacalisir et al.,
2009; Kanter et al., 2010), cyclophosphamide (Cao et al., 2016),
busulfan (Dehghani et al., 2013), etoposide (Okada et al., 2009),
and doxorubicin (Cabral et al., 2014). Moreover, in a testicular
ischemia/reperfusion model using rats, Dokmeci et al. (2007)
reported that the pre-treatment with carnitine (500 mg/kg) pre-
vented the increase in malondialdehyde levels caused by detor-
sion (reperfusion).
In a previous report (Cabral et al., 2014), we showed some pro-
tection promoted by L-carnitine against the damage caused by
the exposure to doxorubicin in pre-pubertal rats, when we could
observe the improvement of the following: (i) the late effects on
spermatogenesis; (ii) the quantitative sperm parameters, and,
more importantly, (iii) the quality of sperm DNA. Using the same
protocol applied here, the benefits of L-carnitine were observed
both in a mid- and in a long-term analyses. These results stimu-
lated the continuity of the study aiming to evaluate the extension
of its beneficial action on reproduction against doxorubicin
cytotoxicity. Also, considering that the integrity of sperm chro-
matin is essential for the transmission of paternal genetic infor-
mation and that it can influence the embryonic development,
we also decided to investigate whether the integrity of sperm
chromatin would correlate with the fertility status.
MATERIALS ANDMETHODS
Animals and groups
Pre-pubertal male Wistar rats (Rattus norvegicus albinus;
n = 48) were purchased from a local animal facility (CEDEME/
Unifesp, Sao Paulo, Brazil) and transferred to the Developmental
and Reproductive Biology animal facility one week before the
beginning of the experiments. The rats were housed in
polypropylene cages (40 9 30 9 15 cm), under standard con-
trolled conditions: hygiene, temperature (23 °C), humidity (45–
55%), and photoperiod (12-h/12-h light/dark). Food (Nuvilab
CR-1 feed, Nuvital, Sao Paulo, Brazil) and distilled water were
provided ad libitum. This study followed the ethics principles
adopted by the Brazilian College of Animal Experimentation.
The experiment was approved by the Ethics Committee for Ani-
mal Research of the Federal University of Sao Paulo, Brazil
(CEUA no.0181/12).
At 30 days of age, rats were weighted and distributed into four
different groups (n = 15 per group), according to the type of
treatment: Sham control (SC), treated with 0.9% saline solution;
Carnitine (CA), treated with a single dose of 250 mg/kg of body
weight (b.w.) of L-carnitine (Sigma C0283, Milan, Italy); Doxoru-
bicin (Doxo), treated with a single dose of 5 mg/kg b.w. of dox-
orubicin hydrochloride (Adriblastina RD; Pfizer, Guarulhos, SP,
Brazil); and Carnitine + Doxorubicin (CAD), treated with a single
dose of L-carnitine (250 mg/kg b.w.) 1 h before doxorubicin
treatment (5 mg/kg b.w.). L-carnitine was diluted in bidistilled
water in a concentration of 50 mg/mL. Doxorubicin was diluted
in 0.9% saline solution in a concentration of 1 mg/mL. Both
drugs were diluted immediately before treatment and adminis-
tered using intraperitoneal route (Sayed-Ahmed et al., 2001).
Rats aging 100 days were reassigned into two different sets,
according to the reproductive outputs: (i) reproductive capacity
and fertility index (n = 24; 6 per group); and (ii) sperm qualita-
tive parameters and oxidative stress measurements (n = 36; 9
per group). At this age, the rats are sexually mature and sperm
concentration in the epididymal cauda reaches its maximum
(Robb et al., 1978).
Collection of testes and sperm samples
The rats used for this purpose (n = 9/group) were submitted
to euthanasia using carbon dioxide inhalation (Hackbarth et al.,
2000). Subsequently, the testes were carefully removed from the
scrota. They were decapsulated, and 0.1 g of samples of each
organ was frozen at 20 °C. On the day of the analysis, the fro-
zen testes were thawed and homogenized in 1.15% KCl solution.
The homogenized samples were used for measuring testicular
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malondialdehyde concentration (MDA) and indirect determina-
tion of nitrite concentration (NO).
The left epididymis cauda was used for sperm collection
according to Vendramini et al. (2012). Right after sperm collec-
tion, a sample of 50 lL was withdrawn for mitochondrial activity
analysis. Aliquots containing 1 mL of 4 9 106 spermatozoa/mL
were stored at 80 °C for the Sperm Chromatin Structure Assay
(SCSATM) and acrosome integrity. The right epididymis cauda
was used to assess sperm motility right after its collection.
Mating
Sexually mature rats (n = 6/ group) were mated with normal
females weighting 200–250 g for fertility and reproductive capac-
ity evaluation. Each rat was mated overnight with two females in
proestrus. At the following morning (considered day 1 of gesta-
tion), females were checked for pregnancy; this test was consid-
ered positive when there were spermatozoa in the vaginal
smears (Vendramini et al., 2012).
Acrosome integrity
The acrosome integrity was assessed based on the methodol-
ogy described by Varisli et al. (2009), with some minor modifica-
tions. To determine the acrosome integrity, we carried out the
staining using ‘PNA Lectin from Arachis hypogaea (peanut),
Alexa Fluor 488 Conjugate’ (Molecular Probes).
Samples of epididymal fluid were thawed and transferred
(50 lL each) to a catalogued Eppendorf amber tubes containing
Alexa Fluor 488 100 mL PNA (20 ng/mL). The samples with dye
were incubated at 37 °C for 30 min; 20 lL samples were seeded
on glass microscope slides and analyzed under an epifluores-
cence microscope Nikon Eclipse Cl (NIkon, Melville, NY, USA)
with appropriate filter. Two hundred spermatozoa were quanti-
fied per slide and were classified as (i) intact (spermatozoa
exhibiting intense and moderate bright fluorescence in the acro-
some region) and (ii) altered (spermatozoa showing weak fluo-
rescence, irregular or absent in the acrosome region).
Sperm Chromatin Structure Assay
The analysis of sperm chromatin integrity using acridine
orange was performed as described by Evenson et al. (2002) and
Vendramini et al. (2012), with minor modifications. The samples
containing acridine orange-stained (AO; Merck/Calbiochem-
USA, Cotia. Brazil) spermatozoa were immediately analyzed
using a FACSCANTO II flow cytometer (BD Biosciences, Sao
Paulo, Brazil). The AO-stained spermatozoon DNA analyzed pro-
duced green fluorescence (detected by a 515–530 nm band-pass
filter) and red fluorescence (detected by a 630–650-nm long-pass
filter). Ten thousand events were analyzed for each sample. The
raw data were processed using WINLIST 3D 8.0 Software (Verity
Software House, Topsham, ME, USA) where the following
parameters relating to the susceptibility of sperm DNA fragmen-
tation were assessed, according to Evenson & Wixon (2005): the
mean DNA fragmentation index (DFI) and the percentage of
cells outside the main population (% DFI).
Testicular malondialdehyde concentration
A sample of 0.1 mL of the testicular homogenate was added to
a tube containing 1.5 mL acetic acid (20%, pH 3.5), 0.2 mL
sodium dodecyl sulfate (SDS: 8.1%), 1.5 mL 2-thiobarbituric acid
(TBA: 0.8%), and 0.7 mL water. The tubes were shaken and
incubated in a water bath at 95 °C for 60 min. Immediately after,
the tubes were cooled and centrifuged at 1878 g for 10 min. The
samples were placed into plates for analysis using the enzyme-
linked immunosorbent assay (ELISA) and the absorbance was
measured at 532 nm. The concentrations are expressed as
malondialdehyde nmol/g tissue according to the methodology
described by Abd-Allah et al. (2009).
Indirect measurement of nitric oxide by evaluation of nitrite
concentration
Testicular nitric oxide (NO) was measured as nitrite as
described by Miranda et al. (2001) and Abd-Allah et al. (2009),
with following minor changes. From the previously prepared tes-
tis homogenate, 0.5 mL was added to 0.5 mL of absolute ethanol
and then centrifuged at 1878 g for 10 min. In sequence, 300 lL
of vanadium chloride (VCl3, 0.8% in 1M HCl) was added to
300 lL of the supernatant. Three hundred lL of a mixture 1 : 1
of Griess 1 (N-(1-naphthyl) -ethylenediamine) and Griess 2
reagents (sulfanilamide, 2% in 5% HCl.) were also added. Imme-
diately after, the solution was left at room temperature for 30–
35 min. Following the incubation, the samples were placed in
plates for analysis using the enzyme-linked immunosorbent
assay (ELISA) and the absorbance was measured at 540 nm.
Concentrations of NO (nmol/g tissue) were determined from a
standard curve of different concentrations of sodium nitrite.
Sperm motility
The motion parameters of spermatozoa collected from epi-
didymal fluid were analyzed using the CASA System (computer-
assisted sperm analysis) with the standard and specific program
Hamilton Thorne Integrated Visual Optical System (HTM-IVOS
Toxicology System, version 12, Hamilton-Thorn Biosciences,
Beverly, MA, USA) for rat sperm motility analysis, according to
the following method described by Klinefelter et al. (1991), with
some modifications.
After the collection, the right epididymis cauda was trans-
ferred to a petri dish containing 3 mL of Hank’s balanced salt
solution (HBSS—KCl, KH2PO4, NaCl, Na2HPO4, and NaHCO3;
pH 7.2), which was supplemented with 2 mg/mL BSA. The plates
were left for 30 min at 37 °C, so the spermatozoa could move
into solution. Then, an aliquot was transferred into a pre-
warmed chamber slide with a depth of 100 lm (LEJA Standard
Count, Nieuw-Vennep, the Netherlands). The slides containing
spermatozoa were placed into a HTM-IVOS Toxicology System
with specific software for rat sperm analysis.
The motility parameters measured were as follows: percentage
of motile spermatozoa, curvilinear velocity (VCL), average path
velocity (VAP), straight-line velocity (VSL), amplitude of lateral
head displacement (ALH), beat cross frequency (BCF), linearity
(LIN), and straightness (STR).
Sperm mitochondrial activity
The mitochondrial activity evaluation was carried out accord-
ing to the methodology of Hrudka (1987). This technique is
based on the oxidation of DAB by the cytochrome c oxidase
enzyme, when the reactant is polymerized and deposited on the
mitochondrial sheath along the sperm midpiece. Thus, the clas-
sification of spermatozoa concerning the mitochondrial activity
followed the subsequent scale: Class I (100% of the intermediate
piece stained, indicating 100% of mitochondrial activity), Class II
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(over 50% of the intermediate piece stained, indicating low
reduction of mitochondrial activity), Class III (less than 50% of
stained intermediate piece, indicating high reduction of mito-
chondrial activity), and Class IV (no staining in the intermediate
piece, indicating absence of mitochondrial activity). Two sperm
smears were obtained per animal. Two hundred spermatozoa
were analyzed under a phase-contrast microscope (Olympus
BX-51 – Japan) at a final magnification of 10009.
Stock solutions of 1 mg/mL 3,30-diaminobenzidine (DAB) in
PBS were prepared with 137 mM NaCl, 2.7 mM KCl, Na2HPO4
4.3 mM, 1.4 mM KH2PO4, pH = 7.4 and maintained at – 4 °C
shielded from light until use. A 100 mL aliquot was added to
each 50 mL sample (a ratio of 1 : 2), and samples were incu-
bated 1 h in the dark and in a water bath at 37 °C. Negative con-
trols were done to avoid non-specific staining of the
intermediate piece; for this goal, an aliquot of epididymal fluid
was previously inactivated at 70 °C, for 5 min. After incubation,
10 lL of the aliquot was smeared on glass slides (Precision Glass
Line, China) and air-dried; after drying, the smears containing
the spermatozoa were fixed in 10% formaldehyde for 10 min,
washed with distilled water, and allowed to dry again at room
temperature. Subsequently, microscope coverslips were placed
on a synthetic resin (Entellan—Merck).
Reproductive competence
The rats were submitted to euthanasia by carbon dioxide
inhalation at the 20th day of pregnancy. In sequence, they were
laparotomized and their uterine horns removed. The implanta-
tion rate, resorptions, and pre- and post-implantation loss rates
were obtained according to the method proposed by Costa-Silva
et al. (2007). The fertility index was calculated as the ratio
between the number of live fetuses and the number of mated
females (Vendramini et al., 2010).
Statistical analysis
The results were analyzed using the SIGMA PLOT 12.0 software
(Systat Software Inc., San Jose, CA, USA). The values with normal
distribution were analyzed according to the parametric test
‘one-way analysis of variance’ (ANOVA), aiming to compare the
independent different groups: SC, CA, Doxo, and CAD. When the
differences were significant, the multiple comparison Student–
Newman–Keuls test (SNK) was used. However, when the values
did not show normal distribution, they were submitted to the
nonparametric test of analysis of variance, the Kruskal–Wallis
test; in sequence, if significant, the data were submitted to the
multiple comparison post hoc Student–Newman–Keuls test. Dif-
ferences were considered significant when p ≤ 0.05.
RESULTS
Acrosome integrity
As shown in the Fig. 1, the number of spermatozoa with intact
acrosome was significantly higher in CAD, CA, and SC groups
than in the Doxo group, demonstrating an improvement of this
parameter in animals previously treated with carnitine. In addi-
tion, rats exposed to carnitine, either alone or before doxoru-
bicin, had the acrosome integrity statistically similar to the
control group.
Sperm Chromatin Structure Assay
The DFI spermatozoa %, which infers the percentage of dam-
aged cells, was significantly higher in the Doxo group in compar-
ison with the CAD, CA, and SC groups (Fig. 2). The mean DFI
did not present significant differences among the groups
(Fig. 3).
Testicular malondialdehyde concentration
The concentration of malondialdehyde in the testis, a marker
of lipid peroxidation, was significantly lower in the CAD, CA, and
SC groups when in comparison with the Doxo group. In addi-
tion, animals from the CAD group presented significantly higher
levels of this marker, in comparison with those observed in SC
group (Table 1).
Indirect measurement of nitric oxide by evaluation of nitrite
concentration
Similarly to the malondialdehyde concentration, the nitrite
concentration in the testis was significantly lower in the CAD,
CA, and SC groups in comparison with the Doxo group
(Table 1).
Sperm motility
Doxorubicin treatment led to a significant decrease in two
progression parameters of sperm motility: VAP (average path
velocity) and VSL (straight-line velocity) but only when com-
pared to the SC group. However, there was no evident improve-
ment of these parameters in doxorubicin-treated rats that were
previously treated with L-carnitine. In addition, the other param-
eters related to motility did not differ among the groups
(Table 2).
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Figure 1 Sperm number with acrosome integ-
rity in SC, CA, CAD, and Doxo groups. Data are
reported as mean  SD. ANOVA and SNK
post-test (n = 6). *Significant (p ≤ 0.05). *Doxo
< CAD, CA, and SC.
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Sperm mitochondrial activity
A significant decrease in sperm number with active mitochon-
dria (Class I) was observed in the Doxo and CAD groups in com-
parison with SC and CA groups. In addition, this analysis
revealed an increased frequency of Class II spermatozoa (more
than 50% of the midpiece was stained) in Doxo and CAD groups
when compared with CA and SC groups On the contrary, signifi-
cant differences regarding the Classes III and IV were not
observed among all groups. Thus, in the condition of this experi-
ment, the previous treatment with carnitine did not improve the
sperm mitochondrial activity of adult rats exposed to a single
dose of doxorubicin at the pre-puberty. In addition, the pre-pub-
ertal rats solely treated with carnitine (CA group) did not show
evident changes in this parameter in any of the classes I to IV at
adulthood in comparison with the control rats (Table 3).
Reproductive capacity
At the 20th day of pregnancy, we observed one dead fetus and
another with abnormal development, in the Doxo group. Rats
from the Doxo group showed a worse fertility index in compar-
ison to those from the CAD, CA, and SC groups (Table 4). The
implantation rate was also significantly lower in the Doxo group
than in the CAD, CA, and SC groups. On the contrary, the rate of
resorptions was significantly higher in the Doxo group when
compared to SC group, although you can check a much higher
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Figure 3 Mean DFI observed by sperm chro-
matin structure assay (SCSA) from control
(Sham Control) and treated rats (Carnitine—CA,
Doxorubicin—DOXO, and Carnitine + Doxo—
CAD). Data are reported as mean  SD; ANOVA
(n = 6). Not significant.
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Figure 2 Percentage of DFI observed by sperm
chromatin structure assay (SCSA) from control
(Sham Control) and treated rats (Carnitine—CA,
Doxorubicin—DOXO, and Carnitine + Doxo—
CAD). Data are reported as median and
interquartile range (Q1-Q3). ANOVA of Kruskal–
Wallis and SNK post-test; (n = 6). *Significant
(p ≤ 0.05). a: Doxo> CAD, CA and SC.
Table 1 Data on testicular malondialdehyde concentration and indirect measurement of nitric oxide by evaluation of nitrite concentration in the control
(SC) and experimental groups (Carnitine—CA, Carnitine+Doxo—CAD, and Doxorubicin—Doxo)
Groups
Concentration (nM/g) SC CA Doxo CAD
Malondialdehyde concentration 161 (95–218) 178 (166–228) 307 (247–351)*a 230 (185–313)*b
Oxide nitric concentration 12 (11–18) 15 (3–17) 28 (15–36)*a 15 (3–36)
Data are reported as median and interquartile range (Q1-Q3). ANOVA of Kruskal–Wallis and Dunn’s post-test (n = 6). *Significant (p ≤ 0.05). aDoxo > CAD, CA and
SC. bCAD > SC.
Table 2 Sperm motility (CASA HTM-IVOS) of animals in the Sham Control
(SC) and experimental groups (Carnitine—CA, Carnitine+Doxo—CAD, and
Doxorubicin—Doxo)
Groups
Parameters SC CA Doxo CAD
Motility (%) 99  1.4 98  3.7 97  1.2 99  1.9
VAP (µm/s) 268  15.5 236  24.8 228  23.2* 246  23.7
VSL (µm/s) 220  32.6 179  19.9 169  21.3* 184  14.1
VCL (µm/s) 372  71.3 354  32.7 346  44.4 368  39.9
ALH (µm) 14  0.79 14  0.77 13  1.2 13  1.3
BCF (Hz) 17  2.0 16  3.9 13  1.0 15  1.7
STR (%) 75  2.5 73  0.8 73  2.3 72  2.1
LIN (%) 53  2.3 51  1.4 50  2.5 51  2.2
VAP, average path velocity; VSL, straight-line velocity; VCL, curvilinear velocity;
ALH, amplitude of lateral head displacement; BCF, beat cross frequency; STR,
straightness; LIN, linearity. Data are reported as mean SD. ANOVA and SNK
post-test (n = 6). Doxo < SC. *Significant (p ≤ 0.05).
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value on Doxo group in comparison with the CAD, CA groups.
Likewise, the Doxo group also showed a higher percentage of
post-implantation loss rate but only when compared to the SC
control group. We did not observe significant differences among
the groups related to the rate of pre-implantation loss (Table 4).
DISCUSSION
Peroxidative damage has been considered the most significant
cause of testicular functional impairment, as consequence of a
variety of conditions involving ischemia, metabolic diseases as
diabetes and xenobiotic exposure (Aitken & Roman, 2008). Dox-
orubicin treatment is associated with damage mediated by a
complex cascade involving production of ROS (Hida et al., 1995;
Jahnukainen et al., 2000) and lipid peroxidation (Suominen
et al., 2003). Resveratrol, ginkgo biloba, nano-zinc oxide, and DL-
alpha-lipoic acid seem to be effective to reduce the reproductive
damage caused by doxorubicin in the testis (Prahalathan et al.,
2006; Yeh et al., 2009; Badkoobeh et al., 2013; T€uredi et al.,
2015).
This is the second study we undertake using a single treatment
of carnitine 1 h before doxorubicin during pre-pubertal phase;
thus, we confirmed the previous assumption that the early germ
cells were damaged by doxorubicin (Au & Hsu, 1980) and par-
tially protected by carnitine in an extent that guaranteed an
improved reproductive capacity and outcome.
The reduction of the oxidative stress in carnitine/doxorubicin
rats in comparison with doxorubicin rats (evidenced in the mea-
surements of malondialdehyde and nitric oxide) seemed to be
the principal mechanism for carnitine protection. Carnitine is a
good scavenger of ROS acting as a protector to the cell mem-
brane (Lenzi et al., 2003) in adverse situations. Although only
two markers of oxidative stress have been investigated, we
suppose that carnitine supplementation improves the oxidative
status and of antioxidant defenses, as observed in hepatic injury
(Alshabanah et al., 2010).
Doxorubicin disturbs the absorption, synthesis, and excretion
of carnitine in non-tumoral tissues (Sayed-Ahmed, 2010).
Importantly, the reduced concentration of carnitine caused by
doxorubicin treatment observed in rat liver is reversed after
exogenous supplementation with carnitine (Alshabanah et al.,
2010). In rats, carnitine is mainly synthesized in the liver and
then distributed to other organs (Vaz & Wanders, 2002). When
given alone, doxorubicin can compromise the carnitine trans-
porters (possibly inhibiting OCTN2—organic cation/carnitine
transporter 2), as already observed in mice by Hu et al. (2012); in
a secondary moment, doxorubicin can cause impairment of car-
nitine endogenous biosynthesis in the tissue (Alshabanah et al.,
2010) as a result of the cellular lesion. Therefore, adequate car-
nitine exogenous supplementation before the exposure to dox-
orubicin could reestablish carnitine homeostasis altered by the
anticancer drug (Sayed-Ahmed, 2010), thus restoring the protec-
tive effect of carnitine, in at least some extent. The possible
involvement of doxorubicin as a potential substrate also trans-
ported by OCTN2, and then competing with carnitine, deserves
a future investigation. However, as the protocols of treatment
and/or models used by Alshabanah et al. (2010) and Hu et al.
(2012) were different than ours, a pharmacokinetic study of the
supplementation of carnitine before the administration of dox-
orubicin in rats should be better scrutinized.
In addition, L-carnitine pre-treatment was reported to be a sig-
nificant inhibitor of doxorubicin-induced NADPH oxidase acti-
vation, reducing the damage caused by this antineoplastic agent
in cardiomyocytes (Chao et al., 2011). In the testis, NADPH oxi-
dase activation is an important ROS-producing source (Li et al.,
2013), feeding the metabolic need of spermatogonial cells for
moderate levels of ROS to facilitate the stem cell self-renewal
that is in parallel regulated by a sequential activation of different
Nox genes (Morimoto et al., 2015). Doxorubicin-induced DNA
damage, besides the role of the topoisomerase II inhibition, can
be caused by direct hydrogen peroxide generation, and it
involves NADPH oxidase activation, which is considered to be a
critical apoptotic trigger (Mizutani et al., 2005). Therefore, the
regulation of the NADPH oxidase activity could indirectly con-
tribute for a decrease of the lesion in spermatozoa arisen from
these cells, then providing more stable chromatin present in the
gametes.
Another alteration caused by the treatment with doxorubicin
is the evident modification of the content and fatty acid compo-
sition of testicular lipids, which probably affects both long- and
Table 3 Analysis of mitochondrial activity in 200 spermatozoa of animals of
the control (SC) and the experimental groups (Carnitine—CA, Car-
nitine + Doxo—CAD, and Doxorubicin—Doxo) groups
Number of spermatozoa
Groups Class I (100%
of activity)
Class II
(activity: >50%)
Class III
(activity:
<50%)
Class lV
(100% of no
activity)
SC 197 (188–200) 3.5 (0.75–7.75) 0 (0–0.5) 0 (0–0)
CA 193 (187–200) 6.5 (0.75–8) 0.5 (0–1.75) 0 (0–0.25)
Doxo 165 (163–196)a* 18 (4–25)b* 4 (1–15) 0 (0–3)
CAD 178 (175–190)a* 16.5 (13–19.25)b* 3 (0–3.25) 1.5 (0.75–2 )
Data are reported as median and interquartile range (Q1–Q3). ANOVA of Kruskal
–Wallis and Dunn’s post hoc test (n = 6). *Significant (p ≤ 0.05). aCAD and Doxo
< SC and CA. bCAD and Doxo > SC and CA.
Table 4 Data of analysis of the reproductive competence and fertility index of control (SC) and experimental rats (CA, CAD, Doxo) mated with primipar-
ous females
Groups Parameters
Implantation rate Resorption rate Pre-implantation loss Post-implantation loss Fertility index
SC 99.40  0.59 0 (0–0.89) 0 (0–0.89) 0 (0–0.89) 13.9  0.65
CA 93.95  2.19 9.09 (0–11.11) 0 (0–0) 9.09 (0–11.11) 13.8  1.30
Doxo 86.82  2.69*a 13.88 (6.73–18.57)*b 3.33 (0–9.98) 14.81 (6.73–23.75)*b 9.9  1.02*a
CAD 93.63  1.19 7.14 (4.54–8.33) 0 (0–0) 7.73 (6.49–8.52) 12.37  0.94
Data are reported as median and interquartile range (Q1–Q3) and as mean  SE. ANOVA and SNK. ANOVA of Kruskal–Wallis and Dunn’s post hoc test (n = 6; 2
females/male). *Significant (p ≤ 0.05). aDoxo < CAD, CA and SC. bDoxo > SC.
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very long-chain polyunsaturated fatty acids (Zanetti et al., 2007).
As carnitine acts as a transporter of long-chain fatty acid from
cytoplasmic compartment into mitochondria, where enzymatic
beta-oxidation and energy production occur, it may have partici-
pated in the reduction in any derangement of the testicular lipid
metabolism that occurred in doxorubicin-treated rats, contribut-
ing to the reduction of the damage in germ cells. Reinforcing this
idea, in non-obese hereditary hypertriglyceridemic rats carnitine
improves the lipid metabolism and has potential protective
action against oxidative stress produced in some metabolic syn-
drome-related disorders (Cahova et al., 2015).
Another assumptive primary target of doxorubicin is the Ser-
toli cell, an orchestrating component of the spermatogenic pro-
cess (Brilhante et al., 2012). OCTN2, a carnitine transporter, is
present in the Sertoli cell membrane (Kobayashi et al., 2005). In
this matter, an in vitro study has already shown that carnitine
acts directly on Sertoli cells improving their physiology and mat-
uration (Palmero et al., 2000). This could ameliorate the
microenvironment within the seminiferous epithelium and con-
sequently, reflecting in the improved quality of spermatozoa.
The main mechanism of the cytotoxic action caused by dox-
orubicin is blockage of the activities of DNA and RNA poly-
merases as well as of the topoisomerase II, being spermatogonia
the preferably damaged cell present in the seminiferous epithe-
lium. Among those cells, doxorubicin is known to especially tar-
get intermediate and type B spermatogonia (Meistrich, 1986;
Vendramini et al., 2010), although spermatogonia A can also be
affected at all phases of spermatogenesis cycle (Matsui et al.,
1993). In addition, doxorubicin also inhibits the DNA methyl-
transferase 1—DNMT1, which is an important enzyme for chro-
mosome stability and transcription (Yokochi & Robertson, 2004;
Vendramini et al., 2012). Indeed, it is a mutagenic and genotoxic
drug (Au et al., 1980; Hacker-Klom et al., 1986) that alters the
expression of genes involved in DNA repair and apoptosis (Wang
et al., 2012). Vendramini et al. (2012) showed that the alterations
produced by a single dose of doxorubicin at pre-pubertal phase
have implications in the paternal inheritance, decreasing early
embryo quality. In the present research, we did not assess the
effect of doxorubicin and/or carnitine on the early embryonic
phase, but we observed an impairment of the reproductive com-
petence in doxorubicin-treated pre-pubertal rats, which were
mated with primiparous females at adulthood. Regarding the
reproductive capacity, Kato et al. (2001) and Imahie et al. (1995)
also reported a significant decrease, despite their report was
developed using a different protocol of treatment with doxoru-
bicin in adult rats. Considering that mechanisms of action pre-
sented by doxorubicin can produce DNA double-strand breaks
as well as a blockage of cell cycle, they can signalize cascades of
events conducing the germ cells to undergo apoptosis. Indeed,
germ cell apoptosis is a well-known fate induced on doxoru-
bicin-exposed dividing cells (Hou et al., 2005; Cabral et al., 2014;
Jia et al., 2015). Injured and abnormal germ cells can be
removed from seminiferous epithelium through the apoptotic
mechanisms. This event can represent an efficient defensive
mechanism aiming to preserve the genomic quality of male
gametes as it has been observed in different adverse situations
(Aitken & Baker, 2013). Thus, it has also been suggested that pro-
tamine deficiency, reactive oxygen species, and abortive apopto-
sis may be responsible for sperm DNA damage (reviewed by Zini
et al., 2014). However, according to Vendramini et al. (2010 and
2012), if abortive apoptosis occurs at pre-puberty and injured
spermatogonia survive, they may develop abnormal spermato-
zoa that will compete with the healthy ones to fertilize the
oocytes.
As previously cited, other studies have been showing the bene-
fits of different substances against the damage caused by the
doxorubicin such as reduction in testicular apoptosis (T€uredi
et al., 2015), and improvement of the integrity of seminiferous
epithelium (Vendramini et al., 2010) and the testosterone level
(Hozayen, 2012) as well as of sperm quantitative parameters
(Jalali & Hasanzadeh, 2013). Experiments in vivo have also
shown that carnitine decreased the reproductive damage caused
by busulfan (Dehghani et al., 2013) and cyclophosphamide (Zhu
et al., 2015; Cao et al., 2016). In the present study, alteration of
the frequency of motile spermatozoa in doxorubicin-treated rats
(treated or not with carnitine) was not observed, although other
sperm quality parameters were.
It must be considered that the most common chemotherapeu-
tic treatment includes not only a single antineoplastic drug, but
also some others, in a combination of different agents that will
certainly cause a distinctive effect on sperm quality and produc-
tion. The negative impact of CHOP chemotherapy (including
doxorubicin) was observed on the quality of male germ cells,
genome integrity, and progeny outcome using the rat as a model
(Vaisheva et al., 2007). However, there are very few experimental
studies that combine analyses of genome integrity and repro-
ductive competence of doxorubicin-treated animals that have
also been exposed to some protective substances (Vendramini
et al., 2010, 2012). This is a gap in clinical and experimental
studies that deserve to be widespread and circumvented.
The investigation of the impact of antioxidants on the chro-
matin structure is a very delicate issue and must be deeply
investigated. The inheritable consequences of the exposure of
the male gamete to cytoprotectors do not necessarily produce
the expected outcome, as already seen in some reports. In two
preceding experimental studies performed in vivo and using
the same protocol of doxorubicin treatment utilized here, we
observed that amifostine, a cellular protector still applied as a
protective treatment, when previously administered to doxoru-
bicin in pre-pubertal rats, reduced germ cell loss, improved
sperm morphology and motility at adulthood (Vendramini
et al., 2010), and seemed to be positively protecting the germ
cells. However, the reproductive outcome signalized that
something was not working well in that drug relationship.
After performing two different techniques to evaluate sperm
DNA integrity, we found that actually, amifostine–doxorubicin
association is very detrimental to the sperm genome and
causes an evident DNA damage and the impairment of the
conceptus development (Vendramini et al., 2012), which justi-
fied the low fertility rate observed in the first investigation
(Vendramini et al., 2010).
On the contrary, the dosage of L-carnitine used in the present
study does not seem to have any detrimental effect on sperm
DNA, fertility index, or pregnancy outcome rate when adminis-
tered with doxorubicin. In a former study, we showed that car-
nitine given to pre-pubertal rats, at the same conditions applied
in the current study, prevented the germ cell apoptosis caused
by doxorubicin and improved many testicular parameters and
sperm morphology (Cabral et al., 2014). We are showing here
that carnitine also preserved the chromatin structure stability
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assessed by SCSA, confirming our previous data obtained using
the Comet Assay (Cabral et al., 2014).
Thus, the alterations in the sperm motility and mitochondrial
activity observed in the doxorubicin groups seem to have not
caused a noteworthy impact on the fertilization process, as no
significant changes were observed in the frequency of motile
spermatozoa in Doxo and CAD rats. On the other hand,
decreases of sperm motility in cyclophosphamide-treated (Cao
et al., 2016) and in diabetic rats (Kang et al., 2011) were
enhanced when they were L-carnitine-treated. However, we trea-
ted the rats at pre-puberty (at 30 days of age) while they did at
adulthood. Also, L-carnitine did not improve the mitochondrial
activity altered by doxorubicin, as presented in our results.
Although optimal mitochondrial function is essential for fertility,
as an energy source for sperm survival and motile capability
(Ballinger et al., 1996), mitochondria-derived ATP seems not to
be crucial for sperm motility; glycosylation has been considered
the main mechanism of obtainment of energy and motility
(Piomboni et al., 2012). Conversely, the reduction in the sperm
DNA damage and the improvement of acrosome integrity and of
the sperm chromatin structure observed in the carnitine/dox-
orubicin group presented a positive correlation with the fertility
index and pregnancy outcome. As the design of the current
study involves techniques that are commonly used in the clinical
practice for evaluating male reproduction, it is possible to pre-
sume upon the sperm fertilization capacity and the risks con-
cerning embryonic loss, information that has been supporting
decisions related to assisted reproductive technology—ART
(Virro et al., 2004).
In addition, there was a positive correlation between the per-
centage of intact acrosome and fertility (Saacke & White, 1972;
Correa et al., 1997). Integrity of acrosome is an important
parameter for the success of sperm penetration into the zona
pellucida (Makhluf et al., 2006). Therefore, morphological
abnormalities in the acrosome or in its size can make spermato-
zoa less able to bind to the zona pellucida, thus compromising
the fertilization of the oocyte (Menkveld et al., 1996; Garrett
et al., 1997). Carnitine plays important roles in sperm motility,
maturation, and capacity of fertilization (Lenzi et al., 1992;
Shang et al., 2006).
Carnitine is an indispensable substance for energy metabo-
lism. In mammals, a balance among its endogenous synthesis,
absorption from dietary sources, and its effective reabsorption
by kidneys preserves the carnitine homeostasis (Vaz & Wanders,
2002). Cancer chemotherapy-induced multiple organ toxicity
has shown to be alleviated by carnitine supplementation, with-
out its interference with the therapeutic antitumoral properties
of these drugs. Thus, the ineffectiveness of carnitine on the anti-
tumor efficacy of doxorubicin was already demonstrated (re-
viewed by Sayed-Ahmed, 2010). There is not much information
about the trinomial: carnitine/chemotherapy/sperm DNA dam-
age and its involvement in the improvement of the reproductive
competence and embryonic viability. Nevertheless, reduction in
the DNA damage caused by actinomycin-D and hydrogen perox-
ide in vitro and improvement in the blastocyst development rate
were already shown by the supplementation of culture media
with carnitine (Abdelrazik et al., 2009), as well as an increase in
the quality of embryos obtained by intracytoplasmic sperm
injection (Abdelrazik et al., 2009) and the nuclear maturation of
oocytes (Phongnimitr et al., 2013).
Finally, there are two subjects that must be emphasized here:
(i) The exposure to chemotherapeutic drugs may cause adverse
effects on the progeny (Hales et al., 2005); and (ii) an intact
paternal genome is essential for successful fertilization and
embryogenesis (Maselli et al., 2014). In the present research, the
quality and viability of early embryos were not evaluated, but
the results of reproductive capacity showed that doxorubicin
increased the embryonic loss in comparison to control rats; nev-
ertheless, carnitine administered alone or previously to doxoru-
bicin did not significantly cause any harmful alteration in the
reproductive parameters covered by our studies, but it improved
some of them. These data altogether have a relevant meaning as
early embryo loss can be a sensitive marker of the adverse effects
of chemotherapeutics on quality of spermatozoa and on integ-
rity of male genome (Vaisheva et al., 2007). However, even if
most of the findings indicate the clinical benefits of L-carnitine,
a few studies have already warned about its toxicity when
administered in high doses (reviewed by Mongioi et al., 2016).
Further studies must be developed to better scrutinize the
referred trinomial. Similar experimental studies are being devel-
oped but using protocols comparable to those used in the clini-
cal practice.
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